Global Isomaltodextrin (IMD) Market Growth 2024-2030

Publication ID:

LPI10250943

Publication Date:

October 15, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Manufacturing (Chemicals) [2]

Chemicals [3]

Description:

Isomaltodextrin听(IMD) is a novel highly branched 伪鈥恎lucan with emerging applications in foods due to its nutritional functionalities.
The global Isomaltodextrin (IMD) market size is projected to grow from US$ 24 million in 2024 to US$ 35.2 million in 2030; it is expected to grow at a CAGR of 6.6% from 2024 to 2030.
The 鈥淚somaltodextrin (IMD) Industry Forecast鈥� looks at past sales and reviews total world Isomaltodextrin (IMD) sales in 2023, providing a comprehensive analysis by region and market sector of projected Isomaltodextrin (IMD) sales for 2024 through 2030. With Isomaltodextrin (IMD) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Isomaltodextrin (IMD) industry.
This Insight Report provides a comprehensive analysis of the global Isomaltodextrin (IMD) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Isomaltodextrin (IMD) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Isomaltodextrin (IMD) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Isomaltodextrin (IMD) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Isomaltodextrin (IMD).
United States market for Isomaltodextrin (IMD) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Isomaltodextrin (IMD) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Isomaltodextrin (IMD) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Isomaltodextrin (IMD) players cover Nagase Viita Co., Ltd, Green Stone Swiss, Orihiro, HB Life, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Isomaltodextrin (IMD) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Purity: >98%
Purity: >99%
Others
Segmentation by Application:
Beverages
Sweets and Snacks
Dairy Products
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Nagase Viita Co., Ltd
Green Stone Swiss
Orihiro
HB Life
Key Questions Addressed in this Report
What is the 10-year outlook for the global Isomaltodextrin (IMD) market?
What factors are driving Isomaltodextrin (IMD) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Isomaltodextrin (IMD) market opportunities vary by end market size?
How does Isomaltodextrin (IMD) break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Isomaltodextrin (IMD) Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Isomaltodextrin (IMD) by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Isomaltodextrin (IMD) by Country/Region, 2019, 2023 & 2030
2.2 Isomaltodextrin (IMD) Segment by Type
2.2.1 Purity: >98%
2.2.2 Purity: >99%
2.2.3 Others
2.3 Isomaltodextrin (IMD) Sales by Type
2.3.1 Global Isomaltodextrin (IMD) Sales Market Share by Type (2019-2024)
2.3.2 Global Isomaltodextrin (IMD) Revenue and Market Share by Type (2019-2024)
2.3.3 Global Isomaltodextrin (IMD) Sale Price by Type (2019-2024)
2.4 Isomaltodextrin (IMD) Segment by Application
2.4.1 Beverages
2.4.2 Sweets and Snacks
2.4.3 Dairy Products
2.4.4 Others
2.5 Isomaltodextrin (IMD) Sales by Application
2.5.1 Global Isomaltodextrin (IMD) Sale Market Share by Application (2019-2024)
2.5.2 Global Isomaltodextrin (IMD) Revenue and Market Share by Application (2019-2024)
2.5.3 Global Isomaltodextrin (IMD) Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Isomaltodextrin (IMD) Breakdown Data by Company
3.1.1 Global Isomaltodextrin (IMD) Annual Sales by Company (2019-2024)
3.1.2 Global Isomaltodextrin (IMD) Sales Market Share by Company (2019-2024)
3.2 Global Isomaltodextrin (IMD) Annual Revenue by Company (2019-2024)
3.2.1 Global Isomaltodextrin (IMD) Revenue by Company (2019-2024)
3.2.2 Global Isomaltodextrin (IMD) Revenue Market Share by Company (2019-2024)
3.3 Global Isomaltodextrin (IMD) Sale Price by Company
3.4 Key Manufacturers Isomaltodextrin (IMD) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Isomaltodextrin (IMD) Product Location Distribution
3.4.2 Players Isomaltodextrin (IMD) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Isomaltodextrin (IMD) by Geographic Region
4.1 World Historic Isomaltodextrin (IMD) Market Size by Geographic Region (2019-2024)
4.1.1 Global Isomaltodextrin (IMD) Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Isomaltodextrin (IMD) Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Isomaltodextrin (IMD) Market Size by Country/Region (2019-2024)
4.2.1 Global Isomaltodextrin (IMD) Annual Sales by Country/Region (2019-2024)
4.2.2 Global Isomaltodextrin (IMD) Annual Revenue by Country/Region (2019-2024)
4.3 Americas Isomaltodextrin (IMD) Sales Growth
4.4 APAC Isomaltodextrin (IMD) Sales Growth
4.5 Europe Isomaltodextrin (IMD) Sales Growth
4.6 Middle East & Africa Isomaltodextrin (IMD) Sales Growth
5 Americas
5.1 Americas Isomaltodextrin (IMD) Sales by Country
5.1.1 Americas Isomaltodextrin (IMD) Sales by Country (2019-2024)
5.1.2 Americas Isomaltodextrin (IMD) Revenue by Country (2019-2024)
5.2 Americas Isomaltodextrin (IMD) Sales by Type (2019-2024)
5.3 Americas Isomaltodextrin (IMD) Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Isomaltodextrin (IMD) Sales by Region
6.1.1 APAC Isomaltodextrin (IMD) Sales by Region (2019-2024)
6.1.2 APAC Isomaltodextrin (IMD) Revenue by Region (2019-2024)
6.2 APAC Isomaltodextrin (IMD) Sales by Type (2019-2024)
6.3 APAC Isomaltodextrin (IMD) Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Isomaltodextrin (IMD) by Country
7.1.1 Europe Isomaltodextrin (IMD) Sales by Country (2019-2024)
7.1.2 Europe Isomaltodextrin (IMD) Revenue by Country (2019-2024)
7.2 Europe Isomaltodextrin (IMD) Sales by Type (2019-2024)
7.3 Europe Isomaltodextrin (IMD) Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Isomaltodextrin (IMD) by Country
8.1.1 Middle East & Africa Isomaltodextrin (IMD) Sales by Country (2019-2024)
8.1.2 Middle East & Africa Isomaltodextrin (IMD) Revenue by Country (2019-2024)
8.2 Middle East & Africa Isomaltodextrin (IMD) Sales by Type (2019-2024)
8.3 Middle East & Africa Isomaltodextrin (IMD) Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Isomaltodextrin (IMD)
10.3 Manufacturing Process Analysis of Isomaltodextrin (IMD)
10.4 Industry Chain Structure of Isomaltodextrin (IMD)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Isomaltodextrin (IMD) Distributors
11.3 Isomaltodextrin (IMD) Customer
12 World Forecast Review for Isomaltodextrin (IMD) by Geographic Region
12.1 Global Isomaltodextrin (IMD) Market Size Forecast by Region
12.1.1 Global Isomaltodextrin (IMD) Forecast by Region (2025-2030)
12.1.2 Global Isomaltodextrin (IMD) Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Isomaltodextrin (IMD) Forecast by Type (2025-2030)
12.7 Global Isomaltodextrin (IMD) Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Nagase Viita Co., Ltd
13.1.1 Nagase Viita Co., Ltd Company Information
13.1.2 Nagase Viita Co., Ltd Isomaltodextrin (IMD) Product Portfolios and Specifications
13.1.3 Nagase Viita Co., Ltd Isomaltodextrin (IMD) Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Nagase Viita Co., Ltd Main Business Overview
13.1.5 Nagase Viita Co., Ltd Latest Developments
13.2 Green Stone Swiss
13.2.1 Green Stone Swiss Company Information
13.2.2 Green Stone Swiss Isomaltodextrin (IMD) Product Portfolios and Specifications
13.2.3 Green Stone Swiss Isomaltodextrin (IMD) Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Green Stone Swiss Main Business Overview
13.2.5 Green Stone Swiss Latest Developments
13.3 Orihiro
13.3.1 Orihiro Company Information
13.3.2 Orihiro Isomaltodextrin (IMD) Product Portfolios and Specifications
13.3.3 Orihiro Isomaltodextrin (IMD) Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Orihiro Main Business Overview
13.3.5 Orihiro Latest Developments
13.4 HB Life
13.4.1 HB Life Company Information
13.4.2 HB Life Isomaltodextrin (IMD) Product Portfolios and Specifications
13.4.3 HB Life Isomaltodextrin (IMD) Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 HB Life Main Business Overview
13.4.5 HB Life Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂